Abstract:Objective The authors’ goals were to determine whether baseline dopamine activity contributes to response to methylphenidate and to assess the pattern of metabolic responses associated with enhanced dopamine activity. Method They used positron emission tomography with 2-deoxy-2 [18F] fluoro-D-glucose to evaluate the effects of two sequential doses of methylphenidate on brain metabolism in 15 healthy subjects. Dopamine D2 receptor availability was measured with [11C] raclopride to evaluate its relation to methylphenidate-induced metabolic changes. Results Methylphenidate increased brain metabolism in six subjects, decreased it in two, and did not change it in seven; however, it consistently increased cerebellar metabolism. Methylphenidate significantly increased “relative”(region relative to the whole brain) metabolism in the cerebellum and decreased it in the basal ganglia. Regional metabolic changes in the cerebellum and the frontal and temporal cortices were significantly correlated with D2 availability. Frontal and temporal metabolism were increased in subjects with high D2 receptors and decreased in subjects with low D2 receptors. Conclusions Methylphenidate induced variable changes in brain metabolism, but it consistently increased cerebellar metabolism. It also induced a significant reduction in relative metabolism in the basal ganglia. The significant association between metabolic changes in the frontal and temporal cortices and in the cerebellum and D2 receptors suggests that methylphenidate’s metabolic effects in these brain regions are due in part to dopamine changes and that differences in D2 receptors may be …

Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors

Decreases in dopamine receptors but not in dopamine transporters in alcoholics

Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: Studies with positron emission tomography

Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction

Differences in regional brain metabolic responses between single and repeated doses of methylphenidate

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers

Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers

Prediction of Reinforcing Responses to Psychostimulants in Humans by Brain Dopamine D2 Receptor Levels

Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate

Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors

Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

Differential Effects of Chronic Ethanol Use on Mouse Neuronal and Astroglial Metabolic Activity

Decreased dopamine activity predicts relapse in methamphetamine abusers

Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications